Involvement of neurotransmitters in the action of growth hormone-releasing hormone antagonist on passive avoidance learning

Behavioural Brain Research

Volumn 233, Issue 2, 2012, Pages 326-330

  Telegdy, Gyula ^a   Schally, Andrew V ^b,c  

^a UNIVERSITY OF SZEGED   (Hungary)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

^c UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

Author keywords

MZ 4 71; Neurotransmitters; Passive avoidance learning

Indexed keywords

(0 ISOBUTYRYL 2 DEXTROARGINYL 6 PARA CHLOROPHENYLALANYL 15 ALPHA AMINOBUTYRYL 27 NORLEUCYL)HUMAN GROWTH HORMONE RELEASING HORMONE[1-28]AGMATINE; 4 AMINOBUTYRIC ACID RECEPTOR; ADRENERGIC RECEPTOR; CHOLINERGIC RECEPTOR; DOPAMINE RECEPTOR; HORMONE ANTAGONIST; MUSCARINIC RECEPTOR; MZ 4 71; NEUROTRANSMITTER; OPIATE RECEPTOR; SEROTONIN 1 RECEPTOR; SEROTONIN 2 RECEPTOR; SEROTONIN RECEPTOR; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; DRUG MECHANISM; LEARNING; MEMORY CONSOLIDATION; MOUSE; NONHUMAN; PASSIVE AVOIDANCE; PRIORITY JOURNAL; PROTEIN FUNCTION;

ANALYSIS OF VARIANCE; ANIMALS; AVOIDANCE LEARNING; DOSE-RESPONSE RELATIONSHIP, DRUG; GROWTH HORMONE-RELEASING HORMONE; HORMONE ANTAGONISTS; MALE; MEMORY; MICE; NEUROTRANSMITTER AGENTS; SERMORELIN;

EID: 84862277218     PISSN: 01664328     EISSN: 18727549     Source Type: Journal    
DOI: 10.1016/j.bbr.2012.05.030     Document Type: Article

References (23)

1. Zarándi M., Horvath J.E., Halmos G., Pinski J., Nagy A., Groot K., et al. Synthesis and biological activities of highly potent antagonists of growth hormone-releasing hormone. Proceedings of the National Academy of Sciences of the United States of America 1994, 91(25):12298-122302.
2. Kovacs M., Kineman R.D., Schally A.V., Zarándi M., Groot K., Frohman L.A. Effects of antagonists of growth hormone-releasing hormone (GHRH) on GH and insulin-like growth factor I levels in transgenic mice overexpressing the human GHRH gene, an animal model of acromegaly. Endocrinology 1997, 138:4536-4542.
3. Gola M., Doga M., Bonadonna S., Mazziotti G., Vescovi P.P., Giustina A. Neuroendocrine tumors secreting growth hormone-releasing hormone: pathophysiological and clinical aspects. Pituitary 2006, 9:221-229.
4. Schally A.V., Varga J.L., Engel J.B. Antagonists of growth-hormone-releasing hormone:an emerging new therapy for cancer. Nature Clinical Practice Endocrinology & Metabolism 2008, 4:33-43.
5. Telegdy G., Tanaka M., Schally A.V. Effects of the growth hormone-releasing h hormone (GH-RH) antagonist on brain functions in mice. Behavioural Brain Research 2011, 24(1):155-158.
6. Tanaka M., Schally A.V., Telegdy G. Neurotransmission of the antidepressant-like effects of the growth hormone-releasing hormone antagonist MZ-4-71. Behavioural Brain Research 2012, 228:388-391.
7. Telegdy G., Tiricz H., Adamik A. Involvement of neurotransmitters in urocortin-induced passive avoidance learning in mice. Brain Research Bulletin 2005, 67:242-247.
8. Ader R., Weijnen J.A.W.M., Moleman P. Retention of a passive avoidance response as a function of the intensity and duration of electric shock. Psychonomic Science 1972, 26:126-128.
9. Sonntag W.E., Ramsey M., Carter C.S. Growth hormone and insulin-like growth factor-1 (IGF-1) and their influence on cognitive aging. Ageing Research Reviews 2005, 4:195-212.
10. Nieves-Martinez E., Sonntag W.E., Wilson A., Donaue A., Molina D.P., Brunso-Bertold J., et al. Early-onset GH deficiency results in spatial memory impairment in mid-life and its prevented by GH supplementation. Journal of Endocrinology 2010, 204:31-36.
11. Van Dam P.S., Aleman A., De Vries W.R., Deijen J.B., van der Veen E.A., de Haan E.H., et al. Growth hormone, insulin-like growth factor I and cognitive function in adults. Growth Hormone & IGF Research 2000, 10(Suppl. B):S69-S73.
12. Donahue A.N., Aschner M., Lash L.H., Syversen T., Sonntag W.E. Growth hormone administration to aged animals reduces disulfide glutatione levels in hippocampus. Mechanisms of Ageing and Development 2006, 127:57-63.
13. Sonntag W., Bennett C., Ingram R., Donahue A., Ingraham J., Chen H., et al. Growth hormone and IGF-1 modulate local cerebral glucose utilization and ATP levels in a model of adult-onset growth hormone deficiency. American Journal of Physiology - Endocrinology and Metabolism 2006, 291:E604-E610.
14. Malek M., Zahedi Asl S., Sarkaki A., Farbood Y., Doulah A.H. The effect of intra-hippocampal injection of growth hormone on spatial learning and memory in animal model of Alzheimer's disease. Pakistan Journal of Biological Sciences 2009, 15:1237-1245.
15. Ling F.A., Hui D.Z., Ji S.M. Protective effect of recombinant human somatotropin on amyloid beta-peptide induced learning and memory deficit in mice. Growth Hormone and IGF Research 2007, 17:336-341.
16. Cogan E. Hormone therapy of ageing:myth and realities. Revue Medicale de Bruxelles 2004, 25:A371-A375.
17. Watson G.S., Baker L.D., Cholerton B.A., Roads K.W., Merriam G.R., Schellenberger G.D., et al. Effects of insulin and octreoide on memory and growth hormone in Alzheimer's disease. Alzheimers Disease 2009, 18:595-602.
18. Leon-Carrion J., Mewrtin-Rodriguez J.F., Madrazo-Atutxa A., Soto-Moreno A., Venegas-Moreno E., Torres-Vela E., et al. Evidence of cognitive and neurophysiological treatment in patiens with untreated naive acromegaly. Journal of Clinical Endocrinology and Metabolism 2010, 5:4367-4379.
19. Vécsei L., Bollók I., Penke B., Telegdy G. Somatostatin and (d-Trp8, d-Cys 24 somatostatin delays extinction and reverse electroconvulsive shock-induced amnesia in rats. Psyhoneuroendocrinology 1986, 11:111-115.
20. Vécsei L., Bollók I., Telegdy G. Comparative studies with cyclic and linear somatostatin on active avoidance behavior and open-field activity of rats. Acta Physiologica Hungarica 1983, 61:43-49.
21. Telegdy G. Neuropeptides and brain function. Frontiers of Hormone Research 15 1987, Karger. T. van Wimersma Greidanus (Ed.).
22. Banks W.A., Morley J.E., Farr S.A., Price T.O., Ercal N., Vidaurre I., et al. Effects of a growth hormone-releasing hormone antagonist on telomerase activity, oxidative stress, longevity and aging. Proceedings of the National Academy of Sciences of the United States of America 2010, 07:22272-22277.
23. Jaeger L.B., Banks W.A., Varga J., Schally A.V. Antagonists of growth hormone-releasing hormone cross the blood-brain barrier: a potential applicability to treatment of brain tumor. Proceedings of the National Academy of Sciences of the United States of America 2005, 102:12495-12500.